G-quadruplex stabilizer 3,6-bis(1-methyl-4-vinylpyridinium)carbazole diiodide induces accelerated senescence and inhibits tumorigenic properties in cancer cells

Molecular Cancer Research

Volumn 6, Issue 6, 2008, Pages 955-964

  Huang, Fong Chun ^a   Chang, Cheng Chung ^b   Lou, Pei Jen ^c   Kuo, I Chun ^b   Chien, Chih Wei ^b   Chen, Chin Tin ^d   Shieh, Fu Ying ^a   Chang, Ta Chau ^b   Lin, Jing Jer ^a  

^a NATIONAL YANG MING UNIVERSITY   (Taiwan)

^b INSTITUTE OF ATOMIC AND MOLECULAR SCIENCES   (Taiwan)

^c NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^d NATIONAL TAIWAN UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

3,6 BIS(1 METHYL 4 VINYLPYRIDINIUM)CARBAZOLE DIIODIDE; BETA GALACTOSIDASE; CARBAZOLE DERIVATIVE; UNCLASSIFIED DRUG; 3,6 BIS(1 METHYL 4 VINYLPYRIDIUM)CARBAZOLE DIIODIDE; 3,6-BIS(1-METHYL-4-VINYLPYRIDIUM)CARBAZOLE DIIODIDE; ANTINEOPLASTIC AGENT; DNA; GUANINE QUADRUPLEX; PYRIDINIUM DERIVATIVE; TELOMERASE;

ANCHORAGE INDEPENDENT GROWTH; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER INHIBITION; CELL AGING; CELL MIGRATION; COLONY FORMATION; CONTROLLED STUDY; DNA DAMAGE; DRUG STRUCTURE; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; NUDE MOUSE; PRIORITY JOURNAL; TELOMERE; TUMOR XENOGRAFT; ANIMAL; BAGG ALBINO MOUSE; CELL PROLIFERATION; CELL SURVIVAL; CHEMISTRY; DRUG ANTAGONISM; DRUG EFFECT; NEOPLASM; PATHOLOGY; TUMOR CELL LINE;

ANIMALS; ANTINEOPLASTIC AGENTS; CARBAZOLES; CELL AGING; CELL LINE, TUMOR; CELL PROLIFERATION; CELL SURVIVAL; DNA; G-QUADRUPLEXES; MICE; MICE, INBRED BALB C; NEOPLASMS; PYRIDINIUM COMPOUNDS; TELOMERASE; TELOMERE;

EID: 50349102258     PISSN: 15417786     EISSN: None     Source Type: Journal    
DOI: 10.1158/1541-7786.MCR-07-0260     Document Type: Article

References (50)

1. Blasco MA. Telomeres and human disease: ageing, cancer and beyond. Nat Rev Genet 2005;6:611-22.
2. Cech TR. Beginning to understand the end of the chromosome. Cell 2004;116:273-9.
3. Ferreira MG, Miller KM, Cooper JP. Indecent exposure: when telomeres become uncapped. Mol Cell 2004;13:7-16.
4. Collins K, Mitchell JR. Telomerase in the human organism. Oncogene 2002;21:564-79.
5. Shay JW, Bacchetti S. A survey of telomerase activity in human cancer. Eur J Cancer 1997;33:787-91.
6. Shay JW, Wright WE. Telomerase therapeutics for cancer: challenges and new directions. Nat Rev Drug Discov 2006;5:577-84.
7. Shay JW, Wright WE. Telomerase: a target for cancer therapeutics. Cancer Cell 2002;2:257-65.
8. Feng J, Funk WD, Wang SS, et al. The RNA component of human telomerase. Science 1995;269:1236-41.
9. Neidle S, Parkinson G. Telomere maintenance as a target for anticancer drug discovery. Nat Rev Drug Discov 2002;1:383-93.
10. Harley CB, Futcher AB, Greider CW. Telomeres shorten during ageing of human fibroblasts. Nature 1990;345:458-60.
11. Canela A, Vera E, Klatt P, Blasco MA. High-throughput telomere length quantification by FISH and its application to human population studies. Proc Natl Acad Sci U S A 2007;104:5300-5.
12. Ludwig A, Saretzki G, Holm PS, et al. Ribozyme cleavage of telomerase mRNA sensitizes breast epithelial cells to inhibitors of topoisomerase. Cancer Res 2001;61:3053-61.
13. Chen Z, Koeneman KS, Corey DR. Consequences of telomerase inhibition and combination treatments for the proliferation of cancer cells. Cancer Res 2003;63:5917-25.
14. Biroccio A, Gabellini C, Amodei S, et al. Telomere dysfunction increases cisplatin and ecteinascidin-743sensitivi ty of melanoma cells. Mol Pharmacol 2003;63:632-8.
15. Tauchi T, Nakajima A, Sashida G, et al. Inhibition of human telomerase enhances the effect of the tyrosine kinase inhibitor, imatinib, in BCR-ABL-positive leukemia cells. Clin Cancer Res 2002;8:3341-7.
16. Sen D, Gilbert W. Novel DNA superstructures formed by telomere-like oligomers. Biochemistry 1992;31:65-70.
17. Zahler AM, Williamson JR, Cech TR, Prescott DM. Inhibition of telomerase by G-quartet DNA structures. Nature 1991;350:718-20.
18. Mergny J-L, Helene C. G-quadruplex DNA: a target for drug design. Nat Med 1998;4:1366-7.
19. Han H, Hurley LH. G-quadruplex DNA: a potential target for anticancer drug design. Trends Pharmacol Sci 2000;21:136-42.
20. Sun D, Thompson B, Cathers BE, et al. Inhibition of human telomerase by a G-quadruplex-interactive compound. J Med Chem 1997;40:2113-28.
21. Read M, Harrison RJ, Romagnoli B, et al. Structure-based design of selective and potent G-quadruplex-mediated telomerase inhibitors. Proc Natl Acad Sci U S A 2001;98:4844-9.
22. Heald RA, Modi C, Cookson JC, et al. Antitumor polycyclic acridines. 8. Synthesis and telomerase-inhibitory activity of methylated pentacyclic acridinium salts. J Med Chem 2002;45:590-7.
23. Gowan SM, Heald R, Stevens MF, Kelland LR. Potent inhibition of telomerase by small-molecule pentacyclic acridines capable of interacting with G-quadruplexes. Mol Pharmacol 2001;60:981-8.
24. Wheelhouse RT, Sun D, Han H, Han FX, Hurley LH. Cationic porphyrins as telomerase inhibitors: the interaction of tetra-(N-methyl-4-pyridyl) porphine with quadruplex DNA. J Am Chem Soc 1998;120:3261-2.
25. Chang CC, Kuo IC, Lin JJ, et al. A novel carbazole derivative, BMVC: a potential antitumor agent and fluorescence marker of cancer cells. Chem Biodivers 2004;1:1377-84.
26. Chang CC, Kuo IC, Ling IF, et al. Detection of quadruplex DNA structures in human telomeres by a fluorescent carbazole derivative. Anal Chem 2004;76:4490-4.
27. Jin R, Gaffney BL, Wang C, Jones RA, Breslauer KJ. Thermodynamics and structure of a DNA tetraplex: a spectroscopic and calorimetric study of the tetramolecular complexes of d(TG3T) and d(TG3T2G3T). Proc Natl Acad Sci U S A 1992;89:8832-6.
28. + is an asymmetric hairpin dimer. Proc Natl Acad Sci U S A 1992;89:10336-40.
29. Chang CC, Chien CW, Lin YH, Kang CC, Chang TC. Investigation of spectral conversion of d(TTAGGG)4 and d(TTAGGG)13upo n potassium titration by a G-quadruplex recognizer BMVC molecule. Nucleic Acids Res 2007;35:2846-60.
30. Gomez D, Mergny J-L, Riou JF. Detection of telomerase inhibitors based on G-quadruplex ligands by a modified telomeric repeat amplification protocol assay. Cancer Res 2002;62:3365-8.
31. Kim NW, Piatyszek MA, Prowse KR, et al. Specific association of human telomerase activity with immortal cells and cancer. Science 1994;266:2011-5.
32. De Cian A, Cristofari G, Reichenbach P, et al. Reevaluation of telomerase inhibition by quadruplex ligands and their mechanisms of action. Proc Natl Acad Sci U S A 2007;104:17347-52.
33. Bond JA, Blaydes JP, Rowson J, et al. Mutant p53 rescues human diploid cells from senescence without inhibiting the induction of SDI1/WAF1. Cancer Res 1995;55:2404-9.
34. Takai H, Smogorzewska A, de Lange T. DNA damage foci at dysfunctional telomeres. Curr Biol 2003;13:1549-56.
35. Damm K, Hemmann U, Garin-Chesa P, et al. A highly selective telomerase inhibitor limiting human cancer cell proliferation. EMBO J 2001;20:6958-68.
36. Huppert J, Balasubramanian S. Prevalence of quadruplexes in the human genome. Nucleic Acids Res 2005;33:2908-16.
37. Todd AK, Johnston M, Neidle S. Highly prevalent putative quadruplex sequence motifs in human DNA. Nucleic Acids Res 2005;33:2901-7.
38. Eddy J, Maizels N. Gene function correlates with potential for G4 DNA formation in the human genome. Nucleic Acids Res 2006;34:3887-96.
39. Siddiqui-Jain A, Grand CL, Bearss DJ, Hurley LH. Direct evidence for a G-quadruplex in a promoter region and its targeting with a small molecule to repress c-MYC transcription. Proc Natl Acad Sci U S A 2004;99:11593-8.
40. Rankin S, Reszka AP, Huppert J, et al. Putative DNA quadruplex formation within the human c-kit oncogene. J Am Chem Soc 2005;127:10584-9.
41. Sun D, Guo K, Rusche JJ, Hurley LH. Facilitation of a structural transition in the polypurine/polypyrimidine tract within the proximal promoter region of the human VEGF gene by the presence of potassium and G-quadruplex-interactive agents. Nucleic Acids Res 2005;33:6070-80.
42. Dai J, Dexheimer TS, Chen D, et al. An intramolecular G-quadruplex structure with mixed parallel/antiparallel G-strands formed in the human BCL-2 promoter region in solution. J Am Chem Soc 2006;128:1096-8.
43. Cogoi S, Xodo LE. G-quadruplex formation within the promoter of the KRAS proto-oncogene and its effect on transcription. Nucleic Acids Res 2006;34:2536-49.
44. Pennarun G, Granotier C, Gauthier LR, et al. Apoptosis related to telomere instability and cell cycle alterations in human glioma cells treated by new highly selective G-quadruplex ligands. Oncogene 2005;24:2917-28.
45. Stewart SA, Hahn WC, O'Connor BF, et al. Telomerase contributes to tumorigenesis by a telomere length-independent mechanism. Proc Natl Acad Sci U S A 2002;99:12606-11.
46. Chang S, Khoo CM, Naylor ML, Maser RS, DePinho RA. Telomere-based crisis: functional differences between telomerase activation and ALT in tumor progression. Genes Dev 2003;17:88-100.
47. Burger AM, Dai F, Schultes CM, et al. The G-quadruplex-interactive molecule BRACO-19 inhibits tumor growth, consistent with telomere targeting and interference with telomerase function. Cancer Res 2005;65:1489-96.
48. Tahara H, Shin-Ya K, Seimiya H, Yamada H, Tsuruo T, Ide T. G-quadruplex stabilization by telomestatin induces TRF2 protein dissociation from telomeres and anaphase bridge formation accompanied by loss of the 3′ telomeric overhang in cancer cells. Oncogene 2006;25:1955-66.
49. Chang CC, Wu JY, Chang TC. A carbazole derivative synthesis for stabilizing the quadruplex structure. J Chin Chem Soc 2003;50:185-8.
50. Dimri GP, Lee X, Basile G, et al. A biomarker that identifies senescent human cells in culture and in aging skin in vivo. Proc Natl Acad Sci U S A 1995;92:9363-7.